bioAffinity Technologies (BIAFW) Cash & Current Investments (2021 - 2026)
bioAffinity Technologies (BIAFW) reported Cash & Current Investments of $3.1 million for Q1 2026, up 675.0% year-over-year from $400000.0 in Q1 2025, and down 51.94% quarter-over-quarter from $6.4 million in Q4 2025.
bioAffinity Technologies (BIAFW) Cash & Current Investments (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAFW) has 6 years of Cash & Current Investments data on file, last reported at $3.1 million in Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $3.1 million, up 675.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (up 675.0% YoY), and the FY2025 annual result was $6.4 million, up 483.54% from the prior year.
- Cash & Current Investments slipped to $3.1 million in Q1 2026 per BIAFW's latest filing, from $6.4 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $13.5 million in Q3 2022 and troughed at $400000.0 in Q1 2025.
- A 5-year average of $4.9 million and a median of $3.1 million in 2026 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2024 and 2025: Cash & Current Investments plunged 90.36% in 2024, then jumped 858.65% in 2025.
- A 5-year view of Cash & Current Investments shows it stood at $11.4 million in 2022, then plunged by 75.28% to $2.8 million in 2023, then plunged by 60.83% to $1.1 million in 2024, then surged by 483.54% to $6.4 million in 2025, then sank by 51.94% to $3.1 million in 2026.
- Business Quant data shows BIAFW's Cash & Current Investments at $3.1 million in Q1 2026, $6.4 million in Q4 2025, and $7.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 462.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 3.26 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 5.70 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 200.53 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 1.81 Bn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 2.10 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 1.10 Bn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 1.16 Bn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 60.60 Mn |
| 10 | bioAffinity Technologies | - | - | - | 3.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.10 Mn |
| Dec 31, 2025 | 6.45 Mn |
| Sep 30, 2025 | 7.67 Mn |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 1.11 Mn |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 2.82 Mn |
| Sep 30, 2023 | 4.50 Mn |
| Jun 30, 2023 | 8.30 Mn |
| Mar 31, 2023 | 9.77 Mn |
| Dec 31, 2022 | 11.41 Mn |
| Sep 30, 2022 | 13.50 Mn |
| Dec 31, 2021 | 1.36 Mn |